← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Visdex Corporation
Berkeley, CA
$2,218,781
Total funding
5
Grants
Funding over time
peak $674.5K · FY2006–14$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,218,781 · 5
By mechanism
R42$1,446,393 · 2
R41$772,388 · 3
Investigators at Visdex Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Phase Contrast OCT for Non-Invasive Imaging of Retinovascular Disease$404,061
R42 · FY2013 · EY
Phase Contrast OCT for Non-Invasive Imaging of Retinovascular Disease$396,465
R42 · FY2014 · EY
Novel Treatment for Post-LASIK Ectasia$347,984
R41 · FY2009 · EY
Novel Treatment for Degenerative Myopia$326,504
R42 · FY2009 · EY
Novel Treatment for Degenerative Myopia$319,363
R42 · FY2008 · EY
Novel Treatment for Degenerative Myopia$270,496
R41 · FY2006 · EY
Characterization of Exudative Macular Degeneration and Diabetic Retinopathy Using$153,908
R41 · FY2010 · EY